Aldeyra Therapeutics, Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
February 17, 2017 16:01 ET
|
Aldeyra Therapeutics
LEXINGTON, MA--(Marketwired - Feb 17, 2017) - Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
Aldeyra Therapeutics, Inc. Proposes Public Offering of Common Stock
February 13, 2017 16:01 ET
|
Aldeyra Therapeutics
LEXINGTON, MA--(Marketwired - Feb 13, 2017) - Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
Aldeyra Therapeutics Announces First Patient Enrolled in Allergic Conjunctivitis Phase 2b Clinical Trial
February 07, 2017 08:00 ET
|
Aldeyra Therapeutics
LEXINGTON, MA--(Marketwired - Feb 7, 2017) - Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
Aldeyra Therapeutics to Participate at the 2017 Rare Disease, Biopharma One-on-One Day
February 06, 2017 08:00 ET
|
Aldeyra Therapeutics
LEXINGTON, MA--(Marketwired - Feb 6, 2017) - Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
Aldeyra Therapeutics Announces Clinical Development Update for Phase 3 Programs
January 25, 2017 08:00 ET
|
Aldeyra Therapeutics
LEXINGTON, MA--(Marketwired - Jan 25, 2017) - Aldeyra Therapeutics, Inc. (NASDAQ: ALDX)
Noninfectious Anterior Uveitis: Enrollment of first-ever vehicle-controlled...
Aldeyra Therapeutics to Present at the 28th Annual Piper Jaffray Healthcare Conference
November 22, 2016 08:00 ET
|
Aldeyra Therapeutics
LEXINGTON, MA--(Marketwired - Nov 22, 2016) - Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
Aldeyra Therapeutics Announces Third Quarter 2016 Financial Results
November 14, 2016 07:30 ET
|
Aldeyra
LEXINGTON, MA--(Marketwired - Nov 14, 2016) - Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
Aldeyra Therapeutics to Present at the Stifel 2016 Healthcare Conference
November 09, 2016 08:00 ET
|
Aldeyra Therapeutics
LEXINGTON, MA--(Marketwired - Nov 9, 2016) - Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
Aldeyra Therapeutics Schedules Webcast and Conference Call for Third Quarter 2016 Financial Results
November 08, 2016 08:00 ET
|
Aldeyra Therapeutics
LEXINGTON, MA--(Marketwired - Nov 8, 2016) - Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
Aldeyra Therapeutics Announces Presentation of Phase 2 Allergic Conjunctivitis Results at the 2016 American College of Allergy, Asthma and Immunology Annual Scientific Meeting
November 07, 2016 08:00 ET
|
Aldeyra Therapeutics
LEXINGTON, MA--(Marketwired - Nov 7, 2016) - Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...